Advancing Non-Invasive Therapy in Women’s Health
Women’s health care in India is entering a new phase with the introduction of robotic High-Intensity Focused Ultrasound (HIFU) in gynecology — specifically for the treatment of endometriosis. This development marks the expansion of HIFU beyond its established role in urology into advanced gynecologic applications involving deep pelvic disease.
This milestone is being highlighted at the Endometriosis India Congress 2026, where internationally recognized expert Gil Dubernard will present clinical insights on High-Intensity Focused Ultrasound for rectal endometriosis.
Endometriosis: A Complex Gynecologic Disease
Endometriosis is a chronic gynecologic condition in which tissue similar to the uterine lining grows outside the uterus. In advanced cases, the disease may infiltrate deep pelvic structures, including the rectum — a condition known as deep infiltrating or rectal endometriosis.
Patients with deep endometriosis often experience:
- Severe pelvic pain
- Dysmenorrhea (painful periods)
- Painful bowel movements
- Dyspareunia (pain during intercourse)
- Fertility challenges
Management of rectal endometriosis is particularly challenging and frequently requires complex laparoscopic or bowel surgery, with associated risks and prolonged recovery.
Robotic HIFU in Gynecology: A Non-Invasive Paradigm
Robotic High-Intensity Focused Ultrasound (HIFU) represents a significant therapeutic shift in the management of selected cases of deep endometriosis.
HIFU delivers focused ultrasound energy to targeted tissue deep within the body, producing localized thermal ablation without incision or surgical entry. Robotic integration enhances precision through image guidance, controlled targeting, and reproducible energy delivery.
In gynecology — particularly endometriosis — robotic HIFU offers the potential for:
- Incision-free lesion ablation
- Preservation of surrounding organs
- Avoidance of bowel resection in selected cases
- Reduced postoperative discomfort
- Faster recovery
This approach aligns with the broader movement toward organ-preserving, minimally invasive therapy in complex pelvic disease.
From Urology to Gynecology: Expanding HIFU Applications
HIFU has already demonstrated established clinical utility in urology, especially in prostate disease management. Its extension into gynecology marks a natural evolution of precision-focused, non-invasive therapy into women’s health.
The Endometriosis India Congress 2026 represents a pivotal moment in this transition, introducing global experience in HIFU for rectal endometriosis to the Indian gynecologic community.
Technology Enabling Robotic Precision
Advanced robotic HIFU platforms such as Focal One integrate:
- Real-time imaging guidance
- Robotic targeting accuracy
- Controlled energy delivery
- Tissue-selective ablation
Such precision is essential in deep pelvic anatomy, where therapeutic accuracy and organ preservation are critical.
Wellnect: Enabling Robotic HIFU in India
As India’s HIFU technology partner, Wellnect is committed to advancing robotic HIFU across specialties — including urology, oncology, and now gynecology.
The introduction of robotic HIFU in gynecology for endometriosis represents an important step toward expanding non-invasive treatment options for women in India. Through collaboration with global experts, clinical education initiatives, and technology deployment, Wellnect aims to support safe and effective adoption of robotic HIFU in advanced gynecologic care.
A New Era in Gynecology: Endometriosis
The emergence of robotic HIFU for deep and rectal endometriosis signals a broader evolution in gynecologic therapy — shifting from extensive excisional surgery toward precision ablation and incision-free treatment.
As clinical awareness and experience expand, robotic HIFU has the potential to reshape the management of selected endometriosis patients in India.
Robotic HIFU has entered gynecology.
Endometriosis treatment is moving toward a non-invasive future.
